Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

Other drug names: A-Am  An-Az  B  C-Ch  Ci-Cz  D-Dh  Di-Dz  E  F  G  H  I-J  K-L  M-Mh  Mi-Mz  N-Nh  Ni-Nz  O  P-Pl  Pm-Pz  Q-R  S-Sn  So-Sz  T-To  Tp-Tz  U-V  W-Z  0-9

Interferon Alfa-2a and Alfa-2b Injection

Printer-friendly versionE-mail this page to a friend
(in ter feer' on)

Brand name(s): Intron A (alfa-2b); Roferon-A (alfa-2a)

Contents of this page:

About your treatment

Your doctor has ordered interferon alfa-2a or alfa-2b to help treat your illness. This drug will be injected under the skin (subcutaneously) or into a muscle (intramuscularly).

This medication is given to prevent tumor cells or viruses from growing inside your body. It does not work for all patients, however, and some patients respond to the drug better than others. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

For the first 10-24 weeks, you will have a daily injection (the induction period). After that time, you will receive an injection three times a week (the maintenance period). Generally, therapy lasts for at least 6 months. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Your health care provider (doctor, nurse, or pharmacist) may measure the effectiveness and side effects of your treatment using physical examinations and laboratory tests before and during your treatment. It is important to keep all appointments with your doctor and the laboratory. The length of treatment depends on how you respond to the medication.

Precautions

Before administering interferon alfa,

Administering your medication

Before you administer interferon alfa-2a or alfa-2b, look at the solution closely. It should be clear and free of floating material. Observe the solution container to make sure there are no leaks. Do not use the solution if it is discolored, if it contains particles, or if the container leaks. Use a new solution, but show the damaged one to your health care provider.

It is important that you use your medication exactly as directed. Do not change your dosing schedule without talking to your health care provider. Your health care provider may tell you to stop your infusion if you have a mechanical problem (such as a blockage in the tubing, needle, or catheter); if you have to stop an infusion, call your health care provider immediately so your therapy can continue.

Side effects

The most common side effect of interferon alfa-2a or alfa-2b therapy is a flu-like reaction with fever, fatigue, irritability, chills, headaches, and muscle aches. These effects should become less severe and less frequent as you continue your therapy. Tell your health care provider if any of these problems continue or worsen.

Tell your health care provider if any of these symptoms are severe or do not go away:

If you experience either of the following symptoms, call your health care provider immediately:

Storing your medication

Store your medication only as directed. Make sure you understand what you need to store your medication properly.

Keep your supplies in a clean, dry place when you are not using them, and keep all medications and supplies out of reach of children. Your health care provider will tell you how to throw away used needles, syringes, tubing, and containers to avoid accidental injury.

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Signs of infection

If you are receiving interferon alfa under your skin, you need to know the symptoms of a catheter-related infection (an infection where the needle enters your skin). If you experience any of these effects near the infusion site, tell your health care provider as soon as possible:

Last Revised - 01/01/2003


ASHP Logo
American Society of Health-System Pharmacists, Inc. Disclaimer

The MedMaster™ Patient Drug Information database provides information copyrighted by the American Society of Health-System Pharmacists, Inc., Bethesda, Maryland Copyright© 2004. All Rights Reserved.